Dr. Yuanli Liu, Dean of Peking Union Medical College School of Public Health, and Lingyun Su, Director of Alibaba Health Research Institute shared their insights on China's health reform and the future of the country's health care system in the China Program Seminar. 

Along with the influx of foreign capital, CFIUS has taken a series of tough measures in recent years. In his talk, Mr. Ji illustrated his viewpoints by making the cross-border investment with the expansion of CFIUS power and covered areas.

Mr. Ji addressed that CFIUS is an elusive problem for investing and merging in the U.S. because of the continuous expansion of the review power, the great discretionary power, the prolonged reviewing circle, and the review method to “discuss each case independently”. Therefore, companies should design a reasonable investment structure with lawyers since the very beginning of investment, properly deal with the interaction with CFIUS, and manage the legal risks that may arise in the investment process.

Dr. Munk addressed that the stagnant healthcare system, the worsening burden of illness, increasing cost and evolving consumer expectations have created much pressure on the U.S. healthcare system. In response, new care models are evolving to provide better and more cost-effective care. These models are disrupting the landscape of the healthcare system and challenging the traditional model of delivering primary care. It is also observed that these new entrants share seven common characteristics: moving upstream, segmenting patient populations, encouraging virtual interlining; adopting risk-based payment structure, occupying space between illness, involving physicians in care teams, and creating new relationships with patients. In his talk, Dr. Munk illustrated his viewpoints with vivid examples and emphasized his optimism for a change and transition in the U.S. healthcare system. 

DNA damaging agent and radiation are the most effective treatment so far for cancer patients, however, mutations that we don’t fully understand arise in tumor empower tumor cell to become resistant to chemotherapy or radiation therapy. In this talk, Dr. Yizhou He, Research Fellow at the Department of Radiation Oncology of Dana-Farber Cancer Institute, described how normal cell becomes a cancer cell and how we can use the genome editing tool CRISPR to find out the secrete of human tumor cell become resistant to chemotherapy.

​

Hospital Information System has been developed in China for more than 30 years. Nowadays, almost every hospital has IT systems sustaining different functions. Peking Union Medical College Hospital (PUMCH), one of the top hospitals in China, is also at the national leading level of construction and application of IT systems. MENG Xiaoyang gives a brief overview of the Healthcare IT development, trend, and ecosystem in China. As an example, he also introduces the Hospital Information System at PUMCH.

​

In just a decade, cosmetic and plastic surgery services have been in huge demand and one of the most popular out-of-pocket healthcare spendings in China. The talk is given by Dr. An Yang, Deputy-Director of Peking University Third Hospital Plastic Surgery Department and a postdoctor at Brigham and Women's Hospital. It introduces the development of China's plastic surgery research and industry, compares China and U.S. markets. and discuss the art and impact of plastic surgery. 

​

The Seminar invited professor from Harvard Medical School, the Dean of Peking University Medical College School of  Public Health, Director of Alibaba Health Research Institute, Chinese Hospital CEOs, and several successful cross-border entrepreneurs. The Seminar attracted over 150 audiences. 

A collaboratory platform for young leaders from the U.S., China, and other countries to participate in developing innovative healthcare solutions and helping to address major public health challenges.

Brainstorm on a diagonal approach to health system strengthening in order to tackle cancer and chronic diseases.

Discuss important issues on and provide valuable insights into the development of the Chinese economy and society since the China reform and opening-up.invited to share their knowledge and experience with the trainees.